Roumell Asset Management, led by Jim Roumell, continues selling shares of Transcept Pharmaceuticals Inc (NASDAQ:TSPT). In a new filing, Roumell reported disposing 7,190 shares, reducing its exposure at the company to around 2.26 million shares. The fund sold the shares in three transactions, with the price being slightly above the $3.50 mark.
Recommended Reading:
Dialectic Capital Cuts Stake in Immersion Corporation
TPG Advisors Cuts Exposure at Armstrong World Industries
Jeff Ubben Helps to Recover Allison Transmission’s Face Value
